Cargando…
Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions
INTRODUCTION: There is a growing and renewed interest in the use of hallucinogenic drugs in the treatment of psychiatric disorders, especially since the FDA approval of ketamine treatment for resistant depression. The response to hallucinogenic psychedelic substances (ayahuasca, psilocybin, LSD, ket...
Autor principal: | Girala, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567945/ http://dx.doi.org/10.1192/j.eurpsy.2022.1820 |
Ejemplares similares
-
Psychedelic medicine and the clinical application of hallucinogens
por: eClinicalMedicine
Publicado: (2023) -
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023) -
A Non-Hallucinogenic Psychedelic Analog with Therapeutic Potential
por: Cameron, Lindsay P., et al.
Publicado: (2020) -
Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
por: dos Santos, Rafael G., et al.
Publicado: (2020) -
Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2019)